LEMAITRE VASCULAR, INC. Impairment of Long-Lived Assets Held-for-use
LEMAITRE VASCULAR, INC. (LMAT) reported Impairment of Long-Lived Assets Held-for-use of $600.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2026-02-26
- LEMAITRE VASCULAR, INC. impairment of long-lived assets held-for-use for fiscal 2025 was $600.00K, a 33.33% decline from fiscal 2024.
- LEMAITRE VASCULAR, INC. impairment of long-lived assets held-for-use for fiscal 2024 was $900.00K, a 87.32% decline from fiscal 2023.
- LEMAITRE VASCULAR, INC. impairment of long-lived assets held-for-use for fiscal 2023 was $7.10M, a 1320.00% increase from fiscal 2022.
- LEMAITRE VASCULAR, INC. impairment of long-lived assets held-for-use for fiscal 2022 was $500.00K, a 400.00% increase from fiscal 2021.
| Period end | Impairment of Long-Lived Assets Held-for-use 12 month |
|---|---|
| 2025-12-31 | $600.00K 10-K · filed 2026-02-26 |
| 2024-12-31 | $900.00K 10-K · filed 2026-02-26 |
| 2023-12-31 | $7.10M 10-K · filed 2026-02-26 |
| 2022-12-31 | $500.00K 10-K · filed 2025-02-28 |
| 2021-12-31 | $100.00K 10-K · filed 2024-02-29 |
| 2020-12-31 | $600.00K 10-K · filed 2023-03-01 |
| 2019-12-31 | $500.00K 10-K · filed 2022-02-28 |
| 2018-12-31 | $1.00M 10-K · filed 2021-03-12 |
| 2017-12-31 | $200.00K 10-K · filed 2020-03-12 |
| 2016-12-31 | $100.00K 10-K · filed 2019-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |